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Ilfl'ROilJOTIOB
Porphyria is recognized as that rare, faailiar, meta
bolic fau1t in which abnolWll kinds and amounts of porphyrins,
eapecial.l.J' uroporphyrins, are excreted in the urine and feces.
The disease may- be latent or aaymptamtic for years, with or
Without the characterietio coloration of' the urine (1).
The word porphyrin is derived fran the Greek "porpharoa•
meaning "purple• •
Porph1rinuria, a laboratory- finding, is found not onl.T
1d. th the disease entity porphyria but in

JllaD3'

disease condi

tions and other abnormal states, inclu.41ng rheumatic f'eTer
and sul.fonmnide intoxication. This urinary- finding is help
ful in the study of the metabolism. of' porpbJ'riDa, which are
found in :many of the respiratory enzymes.
This thesis is written as a discussion of' porphyria in
general and, in particular, the pathogenesis of' porph;yria
and porphyrinu.ria and porphyrinogeneais.

--l-
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NOMDCLATURE
Hoppe-Seyler, 1871, d8scribed a substance, hematoporphJ'
rin, which 1a produced by the hydroly-a1a ot heaoglob1n with
concentrated sulturic acid (2).

In 1893 this substance was

rec06E11Zed 1n the ur� under normal and pathological condi
tions Vi th spectroscopic methods b7 Garrod (3).

Subsequently-,

Fischer and co-workers shoved that the porphyrin ef the feces
and urine, both in health and disease, differs :f'raa. hemato
porphyrin 1n chem.cal structure, behavior, and spectroscop1ca�, and that 1t is uroporphyrin and coproporphyr1n (4 ,5, 6) •
These substances were _named by Fischer according to where
they were f'ou.nd, coproporphyrin referring to the porphyrin at
the i"ecee.

The foi,aa:tion of uroporphyrin is now considered

to be lilllited to idiopathic porphyria (7).
While it has been proved that hematoporphyrin is onl..7 a
laboratory curiosity and never occurs 1n nature, the terms
"hematoporphyria" and "hematoporph,-rin• continue to be found
in the literature.

-2-
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01:IEMISrRY OF THE PORPRIRIBS
The follOVing references were used as sources of 1nf'or
Jlll!!Lt1on in this discussion:
.XYerett, M. R. : Medical Biochemistq, Paul ::S.
Roeber, Inc., lfev York, 1942.
Dobriner, K. , and Rhoads, C • P. :

The Porph,yrins in

Health and Disease, Physiol. Rev. 20:
468,

416-

1940.

Welcher, M. L.:
New Eng.

Meclical Progress:

J. M. 232:

11-19,

The Porphyrins,
1945.

The porphyrins are reapirator.r pis-ients of animals and
plan.ta.

They contain the a;,mra,trical heterocyclic porphine

nucleus which consists of foar p,rrol �11188 united through
methene (-CH•) radicals.

Porphine acids exhibit the phe

nomenon of mesameriaa or resonance, that is, their inter
ataaic linkages exist in an intermediate

state which can be

portrayed equally well by seYer&l arrangements of the unaat
urated bonds.

There is 110 real difference between the several

p,rrol rings;

the two hydrogen ataas vhich are indicated as

attached to the nitr<>sen atcas of rings I and II probably tora
bridges between pairs of nitrogen atoms.
The porphine acids or porpyrins are :metabolites of the
blood pis-ients.

They haYe methyl, ethyl, vin.yl (-CH�B:2),
-3-
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acetic acid and propionic acid radicals substituted for the
hydrogens l to 8 of the porphine nucleus.
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'l'he porphine derivatives are named according to substi-

tutions of the hydrogen atoms by acid radicals. Thus, proto
porphJrriu, ooproporphyrin, and uroporphp-in have two, f'our,
and eight acid r&dicals, reepeettvely.

These substitutions

are indicated 1n the diagram. Mesoporphyrins are obtained
by lllild reduction of virq-1 groups {protoporp)Q'l'in) convertio_g
them to ethyl groups.
Porph1ne caapounds mAY be divided into two groups:

one

{a) having four ea.ch of two dif'f'erent radicals in the eight

substitution points, and the other (b) having three radicals
divided into four of one type and· two of each of' the others.
Examples of porphyrine in group {a} are coproporpbyrin and
uroporphyrin.

There are :four possible isaaers of each

-4-

Uropot>�1n I

ProtoJOl'lfaYrin III
.Kematoporphyrin .�II
Coproporphyrin III
Uropc>ri,h1rin III
Cop�oporpb.yr1n I
-CB3
-ClJaOOQB:

-OHaCOOH

-CH3

-OR3

-CH3

1,3,5
-OH2CH , O()H

-CH�H�OOll
-CH20H2000H
-CH2CII2000H

-CIORO�

-CH:CH2

2 ,Sl
-CH2CH2COOH
-CH2CHZC,OOB
-CH20H2COOH
-CH20H2000H
�HaCH2COOH

6
-Cll2CH2COOR

� ACim

-Cif200()B

-Olt3

-CH2GH2<'00JI
-CH2CHzCOOH

-C1JeCH2COOR
-CR2CH2(JOQR

7

t B)

-CH3
-CH3
-CH3
-CH2<)00H
-CH��C OOH
-CH2QH2000lf

8

----------------------

•

•

-

•

-

compound in this group ) each called a type.
cussed later.

The second group includes protoporphyrin, hema

toporphyrin: mesoporphyrin, deutero9orphyr1n. Fifteen isomers
are possible in this group.
If the eight hydrogen atoms are replaced by four methyl
and four ethyl groups ) four isomeric porphyrins are derived. -·
the etioporphyrins, I, II, III:
nature.

rv.

They do not exist in

These artificial porphyrins are useful as references

for identification purpoees. All naturally occuring gorphy
rins so far analyzed have been found to correspond to etio
porphyrins types I and III.
Protoporphyrin No. 9, a type III porphyrin, is biologi
cally the most important of the porphyrina, it being the
prosthetic group of hemoglobin, myoglobin, cytochrome, cata
lase, peroxidase and chlorophyll.

•

•

-

This will be dis
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OCCURRENCE OF PO.rt?HYRINUF IA

The presence of porphyrins int.he urine is not a pathological ~ondi tion.

The norm:tl urinary porphyrin is c opro-

?Orphyrin I.

It is excreted in a.mounts of 30-50 micrograms

::_:,er day (11).

The normal daily excretion of coproporphyrin

in both stools and urine is 300 to 400 micrograms (12).
Hoagland (13) more recently, 1942, has set the upper limit

•

•

of normal for total u:::-inary porph.}'rins at ).1 mg.

.1\ssuming

this "to be all coproporphyrin I, it compares favorably with
Dobriner's figQre of 30-50 micrograms.

•

•

?orphyr::.ns are normally found in the urine, bile, feces,
meconiurn and all organs

(1-4). Kluver (15) states that nor-

mall,y porphyrins may be demonstrated only :n the central ner-

•

•

vous system.

Porphyrinuria is known to occur in several

anilllals, notably the fox squirrel which excretes large a.m.'.)unts
of uronorphyrin I {16) •

•

•

Pathologically, porphyrinll::'.'ia is associated with many
conditions.

One of the first diseases _porphyrinuria was

found to be associated with was rheumatic fever (17),

•

Other

pathological processes to which porphyrinuria has been attri-

•

buted include pulmonary tuberculosis, ::>leu.risy with effusion,

-

"idiopathic pericarditis" (13), sulfonal tcx:icity (3, 19),

•

•

_pernicious anemia (20), Addison's disease, pericarditia,

-7-
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hemoglobinuria, measles, meningitis, Hodgl:cin's disease, en
teric fever, lobar pneumonia, cirrhosis of the liver, gout,
and chorea

(3). It is also associated with lead and sulfon

amide intoxication (21) and cardiac decompeneation (22).
The relation of many of these conditions to porphyrinuria
does .not appear to be well grounded.

conditions will be discussed later under pathogenesis.

Watson (23) reports that these are not due to porphyrins.

oorphyrin in t,½e ur:nes of 9atiente with untreated pellagra •
The urine returns to normal after treatment with water sol
uble vitamin 3 com�lex or nicotinic acid.

•

•

•

-

On

the other hand, Dobriner and Rhoads ( 24) have reported copro

•

•

Red

pigments have been reported in the urines of pellagra patients.

•

•

Some of the important

-B-

DETERMINATION
The determination of the presence, amount, kind and
type are important procedures in the diagnosis and study of
suspected cases of porphyria.

•

•
•
•
•
•
•
•
•
•
•

•
•

A few of the analytical pro

cedures for determination of urinary and fecal porphyrin are
included here so that the reader may at least have an idea
of type laboratory teats necessary •
The urine of a patient with porphyria is negative as a
rule for all the usual findings:

albumin, sugar, casts, etc.

It is often red, but IDAY be colorless or various shades to
a deep brown or even black.

It may

colorless, but upon

be

standing or being acidified changes color.

This is due to

the presence of the colorless substance porphyrinogen (25) •
Methods

used for the determination of u.:rinary and

fecal porphyrins are as follows:
Garrod's Method:

The urinary phoa�hates are precipi

tated with sodium hydroxide.
about

soi

The precipitates carry down

of the porphyrina present.

The precipitate is dis

solved in acid-alcohol and the 9resence of porphyrins is
determined by spectroscopic examination, i.e., observing the
characteristic absorption spectrum (3) •
Langecker's Method:

This method is similar to Garrod.'s

except that the acid-alcohol filtrate is examined for

-9-
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porphyrins b1 ul.trartolet light.

Deep red fluoreace11ce is

produced ( 26) •
H. J'ischer'a M&thod:

The urine is acidified: Yith gla

cial aoetic acid and extracted Yith ether.
is examined epectroeoopicall,y for the characteriatio-abaor_p
tion epectrUJI..- Uroporphyrin ie not ide.ntified ( 14) •
Gunther's M&thod.:

Feces are dried over a water bath

and then washed Yith •\her and alcohol.

The extracting

:fluid.a are examined apectroacopioall.7 for porpbyrina.

The

washed powdered teoes are then extracted repeatedly Yith acid
alcohol.

The porplqrin DAY be extracted directly vi th ether,

or the acicl-alcohol extract may be poured into a lArSo volume
of water.

A. yellow precipitate forms which is filtered off.

The filtrate is then neutralized, ac1dttied Yith ac.etic acid
and the coproporphyrin is extracted Yith ether.

Uroporplqrin

may be di:f'ferent1ated fran coproporphyrin b7 eolubil11;1 in
ether (27).
Schvartz, Hawkinson and Watson have devised: a quantita
tive Dli9thod for coproporpb,-rin iecae_rs I and III based on
fluoreaeence and differential aolubil11'i,r in 3� acetone (28).
A test for porphob111nogen, a au.bate.nee found. in the urine

I
I
I
I
I

vhieh gives a positive Ehrlich reaotion, has been developed .b7
Watson and Sehva�z.

lqual parts of urine and Ehrlich's reagent

are mi.Xed in a test tube.

An eqwu. volume of' saturated

aqueous eodium acetate is a.dded, followed b7 a small volume
of chl.orotorm..

The contents ot the tube are m1xed.

The

aldehyde cam.pound of porphobilinogen remains in the aqueous
fraction while that of urobillnosen iq oanpl.etel;r extracted
b7 the chloroform..

Watson and Schwartz consider the pre

sence of porphobilinosen to be pathognaaonic of porpb,yria (29).
Speot?Oecopicall;r, oxyhenoglobin and zinc uroporpbyrin
ccapl.e.xes are alaost illlpossible to dif'f'erent1ate.

However,

by addition of hydrochloric acid, uroporphyrin assumes its
characteristic spectl'Ull ( 30) •
Further inf'o:nnation of' pol".Ph,rin determinations may be
found in the llte:rature

I
I
I
I
I
I

(31,

11,

32, g4).

-u-
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OLilfICAL FEATURJ!'S OJ!' PO.RPJl!RIA
Clinical.1¥, the disease porphyria is divided into three
min types:

conaenital, acu.te, and chronic, and a fourth

rare t,:pe termed oligochramenia porphyr1nuria or :megal.o
spl.enica oongenita.
Congenital porp}Q"r;a may have its onset in fetal lif'o.
It predc:ainatee in males and is inherited as a :mendelian re

cessive characteristic.

I
I
I
I
I

r•I

I
I
I
I
I
I

It is characterized by photo-sensi

tivit7 of' the skin in spring and sUD1111er, blistering and scar
formation, red-brown to purple p1glDl')ntat1on of the teeth and
bones.

The skin lesions, vhich resemble h,.-droa aestivals and

h,.-droa. vaccinif'orme, DAY cause severe mntilation (33).
appear as a result of' alight tr&Ullll

(34).

Blisters

Long, f'ine, dOllllY

hair mA1 appear on the f'ace, neck, upper cheat, and extensor
aspects of' the arms (34).

Pigmentation of' the bones m.:t be

determined by trans1llum1nation (35).

A light 1a placed in a

box 1n vhich an inch and one half hole is cut over which the
hand is placed.

Comparison is made with known normals.

Pink fluorescence of the teeth has been observed ( 35) •

A

hiator, of pink teeth is pathogn<mon.1c of congenital porphyria. (33).

An anemia with the appearance of young forms -.y

appear after same time

(35}.

The cl1aical findings of a case described bJ' Aahby (36)

-12-

are as follows: The child's urine altra3a was of a port-Vine .
color, f'roa the first dB.y.

The feces were always dark in

.col.or. Rash and blisters appeared at age four aonths,
follov:tng exposure to aunligb.t. The first tooth was pink:,
darker than the ggms. The u.rill8 was noiw.l except tor color._
There was a alight anellia with over-act1Vit7 ot the bone
marrow suggested by slight anisoc,toeia, punctate baeophilia,
nor-,blAets, and ghosts of nucleated. cells. The skin was
aore subject to trauma than no�, bruised easily, and the
m.rks remained longer than normal.
The porphJrins excrete.cl

iu this tne are uroporplcyr1n

and coproporphJr1n type I (33).
Acute porphp'ia differs fllDdallen-taU, from congenital
porphyria 1n that it ia poes1bl.y inherited as a mend.elian
dcn1nant, appears later in life, usuaU, duriDS the third
and fourth. deoadea, occurs 1n fe•les more f'requentl.7 than
:males, the ratio being about 3:1. !hoto-aena1t1Vit7 is rare,
pigmentation or tho teeth is absent, u.ropol'Ph,rin III is

-1_

most always predominant 1n the urine as a zinc metal ecaplex
al� with other pigments.

OlinieaU,, the disease is .first

indicated by ccaplainta referable to the abdomen or centrai
nervous systea ( 37).
A review 1n 1939 reported 250 recorded cases or acute
-13-
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porp),.,-ria ( 37) •
Acute porphyria is, in reality, a chronic disease char
acterized b;r sudden onset of acute abdaninal cramps, general

or localized to the lover abdomen or about the mabilicus,
associated with nausea, obstipation, and Taniting, which s,:m,p

toms 1l/lJ.1' occur Yith exacerbations and_ remissious over a period
of months to twent;r five ;rears.
JJJAY give

After a variable period. they

w:,- to the deTelopnent of profound psychic and

neurological. disturbances (13, 37).
There ma.y

or Jtay not be f'ever and leukoc;rtoaia (37).

Typicall.7, v1th an onset of abdan:1.nal s,mptcns, there is a
low grade fever, leukoe;rtoeia ma.y be as- high as 20,000 per
cu.. a. m.

Because of this about ooe third of patients �e _

sub Jec_ted to lAparotam.,.

However, the

abd.allen is usual.J.T

soft and the urine is likely to be colored (13).
X-1'8¥ e.xeaination ay reveal dilation of' sai,a sesment
of the gastro-illtestinal tract,
11.eua,

usu.ally duodenum, te:rm1na1:

or a segment of the colon ( 30, 14 :; 38).

Jaundice and piglllentations DAY occur ( 13).
age JJJAY be demonstrated by l.aboratory tests.

Liver dam

Central nervo�

system involvemi,nt J'MlJ be manifested b7 a1)1lptana ranging
- frcm paroathesias and pain in the e.xtreaities to paralysis,
deleriua W1th hallucinations of vision and hearing, epileptic

•

•

-

•

•

•

-

-

seizures, and com.a {13, 38, 14, 30).

Thecl.a.asic type of

neuxologic involvement ie described as an ascending Laud.ray's
ty:pe of paralysis.

Neurological complications occ.ll:' in

ac�te po�phyr�a in about 42fa of cases (39).

Pareses are ir-

regularly distributed, involvement ranging from small muscle
groups to practically all striated muscles cf the body.
'.mere may be Jtosis, facial palsy, diplo_pia, dyaphonia,
dysphagia, and. dysmaseaia..

.aespira.tory failu.re due to bu.loar

palsy is a frequent cause of death.

Pareses may appear sud-

denly or over a period of weeks.
Psychotic behavior, usually of the type called toxic
psychosis or manic-d.e9reasive may be a feature of the dis
ease, usually acconpanied by progressive par�lysis (39).
Menstrual disturbances, particularly amenorrhea, are
frequently associated with the acute episode (40).
sensitivity is rare and comparatively mild (10}.
vascular system is frequently involved.

Photo
The cardio

Hy-pertenaion and

ta.chyca.riia are typical fin.dings ( 13, 39).

�ransient electro

ca.rdiograr1hic changes during the acute e:9isode have been de
scribed; consisting of an elevated ST segment in lead l a.nd
sl�ring of the ST segment in lead 3 (39).
Moat cla.esifi:::at:tons of porphyria incb.de acute �
porphyria.

With the exception of a to.xic factor being pre

sent, these ca.sea cannot be differentiated from a.cute porphyria..
-15-

It 1B generallJ' assumed that in the so-called toxic cases,
the offend.ins substance •rely precipitates an acute P<n."Ph,T
r1a in cases in which there 1s a pro-eXis-titlg inborn error
ot porphJrin metabol.ia. or a ·latent porpbyr1& (l.3).
Past history of ill-dof'ined complaints DAY be preae:tit·.
Often there are vague, poori, localized abdan1nal l)C'ina,
bizarre pains in the extremities or elaevhere, nervousness,
inscmmia, de,preasion, � gonera.Uzod or looalized veaknesa;
the urine occae1onal.1¥ ....,- have been dark or ot red oolor.
Because of earlier ccapJAints the patient -.y have been_
talcins oertain :medicationa, or ma.y- :Jiave been ot.bervise ex
posed to certain toxic agents. such as lead, acetanilid,-nitro
bezaol, sulf'oDAl, trional, barbiturates,

(37}.
The d.1agnoe18 of acute parphJri& depends on evaluation
of the clinical p1ct'lll"8 and m.ust be confuw,d by e.xsmiDAtion
of the urine.

It can be maclo � if it 18 borne 1n mind

and considered as a poea1b1lit.1 1n any un118ual case with e.b
dcn1n&l. pain or central nervous syete:m syaptals (l.4).
To establish a diasnosis, it is coasidered:necessary to
deJIOllStrate uroporph.Jrin in the urine (14), mu.ch of' llhich 1lfAY
be excreted as the zinc ccnp�x (41, 30).

Between attacks

that fraction Which is present as the zinc ccnplex ..,- be
increased.

..J.6-
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These findinga sussest that zinc mtJ.¥ function as a do-t<Kify
ing agent.

The no.l'Blll.ly occurring uripar;y ooproporpb.yrin is

usually increased above the normal �, altholJS}l not a.).vaya,
and when increased, type III predaaine:tea.

Coproporpb,-ria I

and llI have been 1solAt&d fr<n the :f'eces, but � :recently
has uroporphyrin been is<;>la.ted frm the feces (37).
The urine of patients with acute porpbJria -.a.y be per
fectl,J normal. in appearance, but a substance may be present
llbich produces a positive Bhrlich's aldehyde reaction (42).
Thia colorless chrca,sen substance is termed porphobilinogen, which gives a strong red color With Ehrlich's aldehyde reagent
and which ou standing or being acidified and heatod is converted �ly into a rod pigment reeellbl.1.ng urob111n, called
porphobilin, and 1n part to uroporphyriD..

Watson and

Schwartz (29) have devised a test for porpho'bilinogell which
the;r believe to be pa�ogna110nic of porphJria.

Pigmn�s

other than porphyrins probably account 'for -.ny or all of
the colored urines of these patients.
is little undBretood.

Their cheJllical nature

Inclucu,d are melAnin, aka.tole red,

indole, leuci.De, tyrosine, e7stine and urofuacin (29).
Because of the abdaminal pain and associated f'1nd1nss,
patients Yith acute por_phyria 'IIIAY be operated tor acu.te
appendicitis, surgical ileue, cholecy-atitis, ectopic preg-
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nanc1 and ovarian cyst (39, 43).

Addison' e disease •Y be

suggested by the s1Dutltaneous occurrence of lcypoteneion and
pigwentation of the skin.

Blood pressure is ext:remly labile.

Pigmentation d.11'fera tran .�dd1son I s .disease in that the mucus
meabrane is not involved.
The neuroJ.osic manifeqtations mAY suggest a. multitude
or possibilities ( 13, 37).

Most illlp�t is illfectiou polJ':--

neuritis (44 )' which includes the Guil.lain-B&n!e'

syndrome,

acute febrile Pol.JDeuritis, acute polyneuritie with facial
diplegia.

The spinal fluid of acute porphyria is wsu.a].ly

negatiTe except for occasional demonstratable amounts of
porpbJrrin.

Other neurol.Qgic conditiona suggested include

11¥eter1a, ps3choneurosia, acute psyohoeis, encephalitis .,
brain tumor, pollaaelitie, progreesive :m.uscul.ar atrophy,
familial. recurre11t _paralysis, :faaillal periodic pe.ra}J'sis,
diphtheritic po],yneuritia, tiolt paralysis

(45),

triorthoores1l

phosphate poisoning (Jake leg and a.piol paralysis), serum
sickness, and parotitie paralysis.

Other conditions which

migbt be considered are periarteritis nodoea, arsenic poison
.
ing, nicotine poisoning, trichinosis and so-called h,yperten
sive encephalopath,y.
The prognosia of acate porphyria should be extre•ly
guarded.

'l'he disease is in reality chronic, and after its
-18.-
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first appearance it mAY extend oTer a period or years (43, 42)
Of 100 patients who vere the subJeet of' a report b1' WaJ.den
strca. ( 4 3) , 20 died Vithin one year after clinical appearance
of the disease, 2 lived 8· years· and of 12 l1T1Dg patients, l
had lived for 27 years.

The 1.Dmlediate :mortality may be high,

particularly with neurologic manife.station when it may be
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as high as 80-m (43 ., 14).
the initial attack (,1�).

Few Slll"Y'1Te over f'ive years after

J'requent causes or death are re

a_piratory failure :f'raa bulbar palsy, secondary- infeot1on an.d
partioulArly pneumonia ., which may resul.t frolll the patient's
general l,y debilitated. state

associated f'requentl.T With bul

bar waJmess and hepatic insu.ffici&DCJ' ( 14, 30, -46) •
,·

Chronic porphyria includes these cases which cannot be

described as either congenital. or acute but exhibit the
cliuical symptoms of' both (47).

That is, there mAY be akin

lesions on expoaed areas, abdominal, nerv9us or :mental s;ymp
taas, singly or in combiiltion.

Patients Yith thie disease

excrete coproporp)qrin. III and I.

These a.re not �ter

istic of' congenital porphyria. 1n which uroporpbyrin. III pre ..
dom:1natea in tho urioe.

Rovevar, uroporphyr1n I and III have

been isolated (9).
There 1s little dAnger to life, except 1n the eovoreat
cases.

Deaths bet-.e� ages 30 to

65

have been reported ( 69).
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A fourth rare type of' porphyr1a has been described by
Sato and Tak:ahoshi ( 48) to which the name megalosplen1ca

congenita or oligochromemia porphyrinuria has been given.
It has the f'ollov1og characteristics:
l. congenital porphyrinuria with cutaneous sensi
tiVity to light.

birth.

2.

onset at

3.

enlarged spleen at birth with subsequent splencegaly.

4.

chlorotic tn,e of anemia.

,.

tatal term.nation.

6.

:f'aa.ilial. factor (presence of entire a,nc1rale
1n each of the af:tected Jlll!Qlllbera).

The d1aeaae described was fatal Without � app,µ-eut
ccai,llcationa.

In the tvo cases cleaoribed, uath occurred

at 16 8Dcl 18 .ant.ha

or aae.

Pathologically, there was a marked anemia considered
to be due to excessive "hemogl.obinolytic" activity of' the
spleen.

They believed that the hemoglobin was reduced to

form large amounts of porphJ'rins.

The fatal outcome was

thought to be due to the severe anemia.

Suggested possible

therapy - splenectamy.
(lJ7) Ohart-Dif'f'erentiation of Various Types of Por.Ph,ria •
-20-
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Ohronic

t;"'

• I\)

Acute

Ohronie disease

Mi.Xture of co_pl"oporpb,nin
III &I or uropor:pbJ'riQ I,
and Ill

Inherited as a mendelian Uro_po�i&l III excreted
dominant; chronic diee8EB in J.a.rse amounts ohiefl.y
during attacks (reason :ftr
d.asip.tion as ac11\e);
smaller amounts ot copro
porphn!'in III or I found
occasionally

Slis}lt photosena1t1V1t7; some skh
lesions; abd<Xlliaal pa.ill& and symp
tams; 1 t thus re,sembles cODgenital
porphyria in some respects and aNute
porphyria in others

No photosensitivity, no skin�
.sions; great variation in clini
cal picture: a;ymtpoms of three
main types:
l Abdominal: severe o�l:1ke
pain, vomiting and constipation,
often with aligbt fever, hn,er
te1111ion and tach¥cardia
2 Nervous: syminetrical ascending
myelitis (Landi7''s) scaetiJIMts
with neuritis
3 Mental: any- type of :pysob.1o
disturbance; urine during attack
usually red bu.t BIA3' be light st-.w
colored darkening on exposure

"14. -.u

IATION OF VA;aIOUS T
S OF roRPliYRIA
Ty:ge �f.E�ceae Porphyrin
ted. ·
'net OS
n I Yith oopro Great Jhotoeens1tlY1ty,
C ongeni te.l Inher1 ted possibly as a Uropo·.
m&n<lelian recessive; may poli';phJrin I (excreted oon- eo\18 manifestations resembling
tinuou.s 1Y)
"qdroa eativa.le" in spring an!
appear early in life;
ohronio disease
sUJJIIJler, appearing f':req11entl,y in
chilclhood; urine b�gWldy red
with brown tinge; teeth & bones
discolored by uroporphyrin I
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PATJIOLOGICAL ANATOMY
The •Jor Visceral pathology

(30, 14, 38, 40)

at least

from the viev point of pathogenesis is found 1n the liver.
The liver mAY be considerably enlarged.

The hepatic cells

shov changes ranging from. diffuse clou.dy swelling to atrophy
and areas of central necrosis.

They may contain increased

amounts of a brownish yellow pisment;

the Kupffer cells may

be enormously enlarged, the cytoplasm containing much iron
as well as iron-free pisment.
The spleen •Y be increased considerably in size and
shov proliferation of reticular cells and hyalJ.n fibrinOid
changes in the reticular cells of the malpighiaa bodies.
Large amorphous masses of the brow.ish pigment •Y be
scattered throushout as well as being present Within macro
phagocytes Within the sinusoids and also over the entire red
p ulp.
The kidneys may be of bronze color and show occasional
nests of pigment granules, J10Stly iron-free, Yithin the endo
thelial cells of the gl<118rular capillaries and in the c,to
plaSJll of the tubular epithelial cells.

There may be notice

able difi'use cloudy swelling of the epithelium of the tubules
Yith caaplete atrophy in places.
1lll).1 also occur in the glaaoruli.
-22-

The saae degeneratiTI) changes
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The bone marrow may appear hyperplastic and occasional
large cells laden With brown pigment "JNJ.Y be seen.
C_onsiderable llllScle atrophy- may be present.

The heart

mAY' show poor staining of the cross striations ot f' 1bers
with areas of inte119titial rowid cell .infiltration as well
as hemorrhages into interstitial spaces and f'atty (tegenera
tion of' JBllScle fibers.
Before considering the central nervous system. pathology,
it is noteworthy that pol1lh3rins in the pure state are fowid
onlJ' 1n the central nervous system.

nuver

its distribution in the central nervous

(15)

states that

system is_

confined

to the white matter of the brain, spinal cord and cranial.
nerves, except those

whose

The neurological

function is chiefly :motor.

symptoms

appear

_to

be conf'ined

to

the

cerebral·corte.x, the peripheral nerves and to many of �e
cranial nerves, especially the 3rd, 4th, 6th, 7th, 9th, 10th
and l2th.

Symptoms are ref'errable to structures which

according to Kluver (15) do not normally contain porphyrin.
Demonstrable

changes in the

absent or minimal ( 14, 39).
degenerative process of

the

central nervous system.

a.re

When f'ou.nd they consist of �
peripheral nerves and the

anter

ior horn cells, a.n outstanding :feature being a patchy degen
erat1ou of the J11Yel1n sheath.

Changes are described in the

cells o f the s3Jl,I)8,thetio gangl.ions includi.Dg pigm$ntat1on,
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chraan.tolytic and fusion forms of t1groid changes, nuclear
and intracapsular vacuolization of nuclei;
chranatin and no nucleolus;

JllaDJ" showed no

masses of amorphous pigment

were seen in all sections, both iron containing and non-iron
ooo.taining pigmi,nt;

the motor cells of' the anterior horns

of the spinal cord and to a less extent those of the poster
ior home at all levels showed appirent pylmoe1s and
shrinking, and the same types of pisaent were observe4;

the

PurkinJe cells of the cerebellum. showed definite signs of de
generation;

in some places extensive JIIJ"elin degeneration of

the peripheral nerves -was noted as well ae round cell infil
tration, and a f'ev phagoc,tie cells containing brown pigment.
Uroporpli,rin or coproporpbyr-in 1n solution on finel.1 d1Tided
s�te has been dsaonstra.ted --within the cells of the central
nervous system ( 49) •
The h1stopatho1ogy of the porph1-ric hydroa vaccinti'orme
and epiderm.o].J'aia bulloaa do not seem to ditter fraa those
1n nonporph,-rie fOl"IIS of the disease.

�he tendency of the

interpretation of the hiatopathol.ogy- seems to be to ascribe
the necrotic dei.,aal and epide?WLl changes primaril,¥ to capill
ary dNWt.ge 1n the corium prod.Q.ced by light ( 50) •

By means

of fluorescence Jll.croacop1, Borst and Konigsdorffer (1&9)
found extreme],¥ fine granular dapoeita of poriabJriu in the

-24-

papillae illmd1ately beneath the basal oell la,Yer.
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CAUSE OF SIMPrO!tS
What is the cause of pain 1n aeute porphyriaf
As noted preTiouslJ", x-rs.y exsmination shows dilated·
sections. of the gut while laparo-toJQ- may reveal other por
tions in extreme contraction (14).

The action of po�n

on the sJl!P8,thet1c sanglion or saooth muscle of the intestin
al tract may be the cause of pain ( 14) •

Experimental eTi

dence would indicate the actions of porphyria on the auto
nomic nervous system of the intestine may vell produce ab
dcmdnal symptoms.

Porphyrin intravenous}J" or applied loeal.J.J'

has been shown to interrupt the normal rhythmic contractions
which application of atropine does not restore

(51).

Meissner's plexus may be inhibited by porphyrins (38).
These reactions JJJAY be scattered over the bowel so that spasm
and a.tony occur in the ea.D3 portion of the intestinal tract.
The central nervous system m9.nifeetations may well be
due to a toxic effect of uroporphyrin or eoproporphyrin
which may be present in the cells of this system either in
solution or in a finely divided state (49).

Toxic effects

have been demonstrated by injection of hematoporphyrin
(Jhotoqn) for the treatment of ps,chotie depressions With
the development of a severe multiple peripheral neuritis (52).
Ca.rdio-vascul.ar manifestations, notably hypertension,
-26-
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11&y be due to arteriospe.ea. WaJ.denstrca (39) ha.a seen ·
angiospasm of the retinal arteries cluring transient amauro
sis, end changes have been noted in E.lt,G. of a patient with
a.cute porphyria interpreted as due to traneient 117ocardial
ischemia rather than to infarction and evidently resulting
fraa coropary artery spasm (53).
The photodynaaic ef'fects of porpbJ'rins are well estab
lished expertmentall.y (54, 14) but proof of their relation
ship to the skin lesions of congenital and chronic po�ia
are lacking. Photosenaitivit1 in acute porphyria is rare.
When it occurs, it is doubtlessly caused by porphyrimJ. (92).
Porphyrine of type III have lees photoo,naaic action than
those of type I. Because of the fact that patients with
acute porphyria excrete predallinantly type

m

p0l"Ph1r1ns 1-t

might be supposed that this accounts for the tact that photo
sensitivity is a :feature of congenital and chronic porphyria
but is rare 1n acute pol"_Ph7r1a. However, several patients
have been described with acute porphyria who excreted chiefly
type I porphyrin, yet did not exhibit photosensitiv1t;r {47).
.

That porpbµ-ins have a _photodynamic action ha.a been proved
by 1ntraclel"Jllf.U injections of' '98.rious porphyrins {54). The
photosens1t!J1Dg action of porphyrins has not been experi
mentally demonstrated 1n the condition which is most often
attributed to such action, namely, hydroa vacciniforme-.
-27-
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Blum ( 54) states that "In man the lesions acc�ng ex
cess at l)(>l'pbyrina are often produced b7 alight trauma ., and
it is poaaible that this is the usual stimulus for their
f01WLtion.

On the· other hand ., it is possible that light -.y

plAJ' either a direct or an indirect part in their proc!Dotion.
If light 1a a factor, it seems probable that it JlUSt act in
an indirect manner, since exper1mont has not pro"f9d a direct
effect.•
shown.

However ., a direet effect has more recentll" been
Isolated turtle hearts in tandem were pertusod Y1th

a porpbyr1u sol.ution Yi.th no 111-ef'i'ects.

1D the aeries was exposed to light and ahortl.7 therea.f'ter
died.

The second heart was unaffected ., thereby proving tho

direct photoeeu1tir.1ng effect of porpbyrina on tissues (14).

-28-
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TREA'lMll!lfr
In general it 11J1J3 be said that treatment
is unsatief'actor;r.

<?f

porplurria

Morphine '1JJ1!J.7 be required for the abdomin

al and neuritic symptau.

Deto:dcation with metals has �n

tried, based on 'the theori that the metal caaplexee are non
toxic.

For example, tu.roein, a blue pigment found in bird

feathers is a copper uroporphyrin oaaplex.

Copper and zinc

ealte have been used, but with no success (50).
also extensively used.

calcium. 1e

Its use ia baae4 on the dimintttioo

bl' oalciua of the excretion a! p�n 1n rabbit pol'Ph,'
ria (lead) (50).

Mackey and Garrod {35) report oalc1ma

therapy to be of some value in reducing light sensitivity

ot

congenital porphJria.

lfesb1tt (31) considers the use of

calcium to be of little use in aeu.te porphyria, while -Turner
(42) finds that the acute manifestations are alleviated by
intravenous calcima. therapy.
It has been repeatedl.y observed that . there is hepatic
(Q'sfunction with porphyria and that porphyrinur1a was a
characteristic finding 1n rheumatic feTer.

Because of find-

ings suggestive of 11ver damage, a diet high in protein,
carbohydrate, low in fat and Yith a. Titemin B supplement
added, has recent� been used (1), apparently with good re
sults.

A treatment used by- Taylor et al (47) 1s as follows:
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calciua lactate, 2.6 g., sodium. bicarbonate, 5.2 g., ribo
flavin, 40 mg. , ascorbic acid, 400 �- , b7 mouth dai]Jr in
tour diTided doses. In additiou, one ampule ot B concentrate
(SOW B), (thiaain& hydrochlor14B 10 mg., ribotlavin-.10 mg.,
p,ridoxin hydrochloride 5 mg., calcium. pantothenate 50 mg. ,
· and nioot�de 250 mg.) intravenow,]J' and 5 co. of cru.do
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liver extract administered 1ntl"81Ul8cul.Arly dai]Jr.
mnt seemed to &llertate the most d1atress1ng a,mptau but
did uot prevent either the photoaoua1tiT1ty or the increaaed
porphyr1n excretion 1ri the case studied ( chronic porpbyria)
(111).

-30-

PATHOOENESIS
Idiopathic Porpbyr1n
-All unicel:].ulAr organiB1U are capable of producin8 por
pbyrins ('6).

This formation appears to be a characteristic

of growing cells, so that in the adult the formation of por
l)b3r1na due to the •Jori t,- of cell.a is alight.

The heJDO-

poietic SJ'Stea 1n the fomation ot hemoglobin is a system of
great activity and.
. it 1s here that evidence tor _cellular
�
porpbyrinogeneeis lllUSt be sought.

Fluorescence charaeter

istics of the thr�e types of porphyri,µs (protoporpbJl-�,
coproporphyrin, uroporphJrin) has been ·observed in er,thro
blAste, gradually fading as the addition or iron and pro

tein has dampened it. (57)
Waldenstrca (39) has susgeeted that po�i& might be
a severe disorder of ..,-oglobin metabolisa.

As hemogl.obin con

taiDa ·· the porphine nucleus one might suspect that the por
J.>h1'r1ne arose f'roa hemoglobin destl'UCtion.

This vas the

contention of Garrod (22) who not� porphyrin�a 1n various
conditions, ne.tably pernicious anemia, lead poisoning and
liver disease.

Thia voul.d indicate that porphyria is merely

an exacerbation of the normal mechanism. of porph,yrin foma

tion.

This cannot be the case as it does not explain the

formation of u.roporphJTin - the normal porphyrin is copro-

-31-

porphyrin

(7) - neither

does it explain the oocurrence of

type I ccmpounds - h90globin being a type III caapaund.
Garrod (58) J.e.ter exple.ined this as a.n "inborn error of metab
olism."

Dobriner and Rim.ington (31, 20, 59, 6o) have since

considered the porphyrins of porphyr1a to arise during hemo
poiesis rather than during heao-deatru.ctioa.

In P?rphyria,

the frequent demonstration of zinc uroporpbyrin, as well as
other porphyrins in the peripheral portions of 11ver lobules,
suggests the possibility that in this condition cells other
than erythropoietio � be active in porphyrinogenesia

(57).

'Dobriner ( 11) states th at the formation of type I
porphyrin has no direct connection with that of hemoglobin,
but

that an increased coproporphyr1n I excretion 1s associated

with an increase in heaopo1et1c activity (59). Tl1nler (16,
50, 42) has presented evidence which suggests that porphyrin
may represent

a persistence of fetal pyrrole metaboliaa. To

be more specific, Borst and lCon1gsdorf'fer (49) came to the. conclusion that uroporphyrin and coproporphyrin are synthe
sized in the megaloblaets and tha� these are rapi� destroyed

liberating the porphyrins.

They found that in fetuaee and

in subjects with pernicious anemia the megaloblasts apparent
]J' synthesize uroporphyrtn and
Fischer's

coproporplqrin.

(61) demonstration (a) that

Petr,-'eit

In v1ev of

porphyrine

were of t'ype I, vhereae hemoglobin 1s derived. from a type III
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porphyrin, and (b) that the one could not act as a source or

der1ffit1-ve of the other. Borst and Konigsdortfer (49) con
cluded from. their own clata. that Porphyria represents the por
sistence of a f'etaJ,. s� of pyrrole :metabolism vhich is en

tirely" independent of' and apart from normal hemoglobin meta. bo�ia..

'lb.eae f'1nd.1nss are corroborated by Turner's (16)

study of squirrel por_pbyra in which there is a continuat1<>J?.
· of ncretion of-uroporp)lyrin I 1n a.dult. lil"e vhioh is asso
ciated With staining of the fetal. bones.

* A classical case of porphyria tram which much clinical in
fora.tion was deri-ved..
Por_phyrinuria
Raving discussed idiopathic pO?'Ph,ria, an attempt Will

be made to discuss the Pathogenesis of PDl"Ph,rinuria or the
so-called secondary porphyr1m associated with other prillary
patholas7.

Porphy:rinuria is associated Yi th many diseases,

1n·eame more or leas consistently" and others as an occaasion
al observation With little d.em.onstrable relationship to the
disease process.
S;ymptoms of acute porp}qria, D811191.y;

nausea, colic,

vcn1.ting, constipation and muscular weakness bear a certain
reeemblAnce to those encountered as a result of sulfanilmnids
toxicity-.

Photosensit1v1ty, •nil"ested by rash, has been
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observed appearing 8 to 9 days after starting sulfanil.amide
therapy.

The urinary- porphyrins were noted to be increased.

Experi111entally, sulfanilam1.de porphyri.nuria has been pro
duced in rats.

The porph:rins present are large]J copropor

phyrin III and a trace of coproporp}Jlrin I.

mal rolationahip of Type III to Type I.

Th,is is the nor

'l'he source of thee

p_prphJrins is apparently fraa blood break-down, but there is
no evidence to ahov th�t a porphyrin stage is inTOlved in the
change frca hemogl.obin to bil1rub1n {63).

The spleena of ani

mals at the height of sulfanil.aaide d.osing are of a bl.ack1ah-
brown color, 11.uch engorged and show extenstve deposits of
greenish-brown granular p18J18nt, mu.ch stainable iron., and a
certain- amount of porphyrin ( observed fluorosco_pically) ( 21.}.
'!he action of sulfan11.am1de may be·aiJD.11.ar to that of lead
vhioh is thought to act by interf'erring vith th�meohanism.
of incorporation of iron into proto_porphyriD to produce hema
tin (2l).

In -a study ot a series of eulfonaioe drugs tested,

Billlington and Hemmings (62) found that all substances exerting
a porpbµ'inuric action are also .capable of producing meth

--

hem.oglob1nemia in vivo.

It has been found that to increase

po!"Ph1r-1n excretion the presence of an aranatic amino group
is necessary.

This amino group Dll18t be eu'bstituted or poten

t1.ally free and pref'erab}3 situated 1n such a sy-stea that it
is capable of undergoing oxidation Yith tho f'o:rm,3.t1on
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or- a

hydroxyl.amine derivative

or a reversibly oxidizi,qg w•tem
Rilllingt� and Hemmi�

suoh as p- or o- iminoquinone (19).

(62) thought that :methemog!obin, when once formed, is' clegraded in part at least, by a mecha.niam which leads ultiml!iteti:
not to bil.e pigment but to porphyrin.

They considered the

source of extra coproporphyrin Ill to be from an increased
breakdown of blood pigment.

Hema.tin zy be an ift.'tormediary

stage.
Lead has been preViously mentioned as interterrip.g with
the mechanism of incorporation of iron into RrotoporpbJ'rin
to produce hema.tin (63).

Coproporphyrin III has been iso

lated fro.m. the urines of patients with lead poisoning.
As noted previously, eplenomegaly has been found to
occur in porphyria.

The spleen has been shown by splenec

tomy (22) to play no part in the pathQgOne�is of porphyria
w1 th the probable exception of -the rare type oligochromemia
porphyrinuria.
Garrod (22) believed that the liver ia the organ in
which "hema.toporphyrin" is formed.

He described a va.:r:ietj'

of diseases including valvular heart disease, tuberculosis,
lead poisoning and gout with pathology including passive con
gestion, cloudy swelling, fattr degeneration and cirrhosis in
all of which porphyrinuria was noted.

Dobriner ( 11) noted an

increased.Doproporphyrin III excretion in pigment cirrhosis
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.(he:mosiderosia) and liver tum.or.

Watson (1,) isolated eopro ..

porpbyrin I f'ran. urino of a patient With hepatic cirrhosis,
Copropor_phyrin III has been iso

pro'bab4 due to cinoophen.

lated :f'raii the urines of patients w1th lead poieoning ( 64) •
Porfuaion exper:im,nta show that the 11 ver is oal)8ibl.e of con
verting protoporph,rin into coproporphJrrin.

Ooproporplintin

of the urine and bile is �lJ' to arise fran. the protopor
�n ot the eeythrocytes ( 64).
Watson ( 66)

!las

noted the · excretion of co.propol"Pblrin I

fran. a case of pernicious anemia.

Dobriner and Rhoades (20)

in their studies of pernicious anemia concluded that �e
rates

or

excretion

or

coproporphyrin I and urob111n are

elevated during relapse and are restored to normal b3" speci
f'ic therap7.

They state that hemol,ysia is a factor in

pernicious anemia end that sim.11.a.r changes a.re produa.d in

I
i_l

1.

I
I
I
I
I

induced hemol.Tt1c states.

In their experiamta with dogs

( 67) in which a volwne of blood was remoTed, they- f'ound an
increased excretion· of coproporphyrin I.

They noted that the

rate of excretion of coproporphJTin I varied as the rate of
formation

ot

type III porphyrin as new hemoglobin.

Copro.1>0r

�1n is probably a b7-procluct of the s,nth�sis of the type

m porphyr1n ccnpounds / and the

rate of excretion of copro

porphyrin I is probably an i�x of homopo1et1c activity
under normal conditions.

36
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PorphJrinuria ia a characteristic finding in rheumatic
fever ( 69) , • in wh1' h it was first observed in 1880 by_ MaoMunn
(17). A s:;uay of 41 cases or acute rheumatic fever was made
They noted a marked increase in por

by Kapp and Coburn ( 68).

phyrin excretion accompanied bY" or shortl.3 tollowing the on
set

or

rheumatic a.:,mptams.

The intensity of porplJyrinuria

was strikingly greater in the severe than in the Dlild rheu- ·
ma.tic attacks.

A normal. urinary excretion

found in quiescent rheumatic patients.

or

po�illS was

The porphyrin was

identiried as a type III copropor:p.b,-rin and was usual.l.J' can
bined With a metal.

"Evidenoe is cited that a. widespread iu

te�erence with -various c011Stituents involved in tissue oxi
dation occurs in rheumatic :fever - that is, porp}Q'rinuria,
lowering

or

plasma ascorbic acid-::, and vitamin� l.e-vels and

changes in glutat.Jtiooe"

(69).

It has been noted that an anemia develops at_tblee 1n
congenital porphyrta associated with evidence ot over�tiTity
of the bone marrow manifested b7 an1aoc,to ■ 1e, pmct6•
basophilia, nOl"DlObl.aete, and ghosts of nu.cleated red cells in
the peri:pheral blood (36, 50).

In this regar-d, data obtained.

f'raa a study of Petry is of particu.1.ar interest.
to 1919 Petry excreted fram. 0.17 to
per dAy.

o.6

J'ram. l.915

grams of uroporplqrin

Thip excretion of uroporph.Jrin correeponds to an

excretion of hemoglobin of frOlll 2.9 to ·10.3 grams per-cla,r,
-37-
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not 1ncludill8 the exoretioo. or coproporphyrin. Th.is re:r,re
sents an enl)rmous Pl'ITOl :metabol181ll and b7 Yithch'aving tran
the sources of hemoglobin, �t lead to anemia.

This showed

up 1n Petr,-•s blood counts (70). Petr;r, who early shoved a
high color index, was found at autops1 to have mesa,loblaats
in his bone marrow and extramedullaey' erythropoieeis.

This

m.y explain why' a lArge number ot patients show no eTidence

ot

a_ pr� anemia 1n the peripheral blood (50).
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PORPllYRil'lOGIIS
The nature of the precursors ot the pot'Ph7rins has been
a matter or speculation tor .rears.

Recently, 'by the use of

isotopic elements, more direct information has been obtained.
Proline, oxyproline aud tryptophane, because of their
chemical configuration, have been suggested as sources of
porplqrin (10).

Turner (57) considers tryptophane, to be

the oiu.,- amino a.c14 which could conceivab]J' be a precursor
of' pJTTOl .

This would. require the improbable, but possible,

opening ot the benzene ring of the indole nucleus of trypto
phaoe.
known

Thie llight occur b1 an oxidative reaction, such as is

tor

tyrosine and quinone.

There is no eTidenee that tryptophane is ·essential in
formation of hemoglobin (57).

Hence it is unreasonable to

assume that tryptophane is a precursor of the porphyr1ns.
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Study with yeast

and

Rard.er's

glands of

rats points

to

the probability that carbohydrate and s1-t>le amino acid Jlll9ta
bolism is close}J' relAted to porphJrinogenesia ( 57) •
Glutamic acid J'JJAY be condensed into pyrrolidbn car'box3lic acid.

The conversion

of

th is into proline or pyrrolidin

carbox.,-lic acid made 1n same such manner 1IIAY' bo a precursor
I
of the porphyrins ( 71) •

Leueine (72) and ammonium. (73) as the citrate, which
were marked with ieotopic nitrogen and fed to rats, have

I
I
I

been shown to _play no part 1n the s,nthesia of the porphy'rins.
G}J'cine has definitely been proved to be a porphyrin
precursor.

Glycine containing isotopic nitrogen was fed to

human subjects over a three day period.

It was found that

the 1'15 concentration in the hemin prepared from blood. samples

I

reached a maximum in 30 days and that 1n the plAsma protein
reached a minim.um in that time.

On the basis of

!!! !!!2 ex

per1Jlll9nts 11; was concluded that protoporplcyri� is s,nthe

I
I

sized tre.a acetic acid or same closely related compound and
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Ana:Logous _!!! vitro reactions also occur (74).

glycine.

Flecher

(75)

in

194�

found that a positive color test

for p,rroles could be obtained after condensing fo:nvlacetone

I

w1t h gly'cine.

I

Acetic ao1d is the only aoetylating agent for aranatio amines

Acetate has been shown to take part 1n po�1n synthe
sis by a technique s1m1lar to that used Y1th gl,J'cine ( 76).

and the lll!LJor one for �-amino acids (76).

The maJor portiOQ

of acetic acid. probably arises from ,8Q'&iaation of fatty
acids.

I

78)

Acetic acid has been condensed to aoeto-aoeta.te

(:n,

and by �ondensation of aoeto-aoetic ester and ammonia

pyrroles have been formed.
for PJlTOles.

This is the ltnorr synthesis (79)

Conceivably, s:lmilar reaotiona zy occur in

the body.

I

Porphp-1ns have been synthesized from pyrrole and
al.de�s (formaldehyde, acetaldehyde and furald&hyde) (80).
A possible mechanism of this synthesis vill be shown below.
While some of the precursors of the porphyrins have been
determined e:r;perimentall.1', the mechanism of their incorpora
tion into porphyrins is only speculative.

AnY theor;r of

por.phyrinogenesis must e_x,pl.a.1n:
1 ..

the occurrence a! the folloving porphyrine:
protoporphyrin 2, protoporphyrin 9, coproporphT,rin

I

I
I
I
I
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I and III and uroporph;yriri I and III.

2. the normall.3' great preponderance of protopo�in
3. the appearance n� of emall and equal amounts .
of the tvo coproporphyrin isomers.

4. the extremely

rare

occurrence of the uroporphyrin

isaners.
The follovi.Dg ie a theory proposed b7 Rimington (21.).
He explains the formation of porphyrins tram. tvo dissimilar
dip,rxamethenes, each one half' a porphYJ:in ri�, Yith euit
-42-
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able radicals attached ,. called x and y.

The radicals or the

dip,-rramethenes are so arranged that when x and y uni-te a
PQrphyrin such as protoporpbJrin 9 { type llI) is formed.

This

reaction is controlled by enzymes, but a sm.11 fraction of x
molecules combine With other x molecules to form a type I
porphJrin.

I
I
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It would "be reasonable to expect a relatively

small number of dipyrranethene y :molecules to unite, With ea.eh
other to form type II porpbyrine, but none has ever been
foUDd in nature.

Uroporphyrin I and coproporph:rin I a.re

eX!)lained as breakdown product•.

A -1:�pel
pc1tr"1v-·&I\ wi.t�
-ivl-�I q�w.ps

A �y,�If por1L�;,.
� P">io•u�
,,o,,..pr �11J 1
mef'-1 I '"ufN

,,
'i,.,..,s�t-1la '4-yr-t�-

lolSl .. f

-"' 4

�l:,'c.� cowi1oa.

.J}

Co,roro�pL1ri� I
v�or·•rp�1r;� I

11t,
T1 rt. 1f d
Prof•ror r�1rir1 9

tr.,,, :cri)

ll tv ear

-Ms

rotAAA,J..

••tw.�.
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Turner

(57)

considers the enzJ1D&tic control theory to

be too general and proposed. a theory starting With pyrroles
as build.igg blocks.

I

M I

PA
NH
P�rroi Jil

�

P�n1·ol

1I

By simple decarboxy-lation of the acetic acid group,
pyrrol I is transformed into pyrrol II;

dehydrogenatiO!l and

decarboxylation of pyrrol II leads to pyrrol III. �se re
actions are well known biologic processes, and it is imagin�
able that pyrrol I ma.y actually be the pr:l.mal7 building block
of the naturallJ" occurring porphyrins.
Pyrrol I DAY" vell undergo an aldehyde synthesis to form.
a pyrromethene.

Corwin and Andrews ( 81) have shown that in

the aldebycle synthesis of pyrromethenes
diary formation of tripyrranethene.

there is an interme

If' such a tripyrramethane

were f'ormed ot the pyrroJ. I units, it mAY have the fol.loving
form, which, on passing to the pyrromethenes, may lead to
uroporphyrin

I, II, and III.
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/
/.

j

,,/pA

/

,I'

,_

PA

Uroporr��ri11 I

Su.eh a synthesis Jl1U8t be. very rare for it is seldom
found 1n WLture and it must occur o� When the acetic acid
group ie protected frClll carbox.ylation. Pyrrole of this type
are unstable, losing carbon dioxide sponta.neo\161.y at roan
ten,.pera.ture.
The formation of hcaologous tri.Jnethyl, triproponic
acid, tripyrranethane :might explain the f'ol'llll!Lti-on of the

I
I
I
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I
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coproporph,rins.
The pred�nance of protoporph,r1n as the apex of pyrrol

metabolism indicates strongly that the extent of the forma
tion of p,rrol III must be large.
The formation of protoporphyrin 2 and protoporpbyrin 9
11J/3.1 be accounted for by the intermediate· formation and dBcC111position of tripyrrcmiiertbane according to the cause incllcated

MOV
l
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H

H

MOPA

-cH = �
a

PAQ l'I

t::r
.

-C.
H =.

ti

. b

ttfl ,
A

.

The f'orma.tioo of pro�oporphyrin type ll is to be expected.
If this theor.r is correct, this will be found ,- unl.Bse there
1s some purely chemical reason, posaib� associated With sub.:.
stituents on the l or 4 poaition of the ,PJ'I'TOl rings, which
wou.1d preclude it.. Etlz3]118s probably play a part.

Zinc PJ"O

bab].J" plays a part as this metal 1s almost universally asso
ciated with uroporphyrin and coproporphyrin.

I
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GENERAL _GODBIDERATIONS AND SUMMARY
The clinical characteristics and diagnosis of the idio
pathic porphyrias have been discussed.

While the idiopathic

porphyr1as are not ot great importance in regard to frequency,
they are of importance because of their resemblance to the

I
I

acute abdomen, eertain neurologio, psychiatric, and dernata
logie conditions.
The principal pathologic findings are found in the
skin and central nervous system.
Pharmaoologiaal.l,y, porphyrins produce s;ymptams by photo

I
I

dynamic effects, direct action on smooth muscle, aJld, direct
action on the central and s,mpa.thetie nervous system,.
The idiopathic por_phyr1as, eongeni tal, acute and chronic,
in reality, are all chronic diseases and are familial in
nature.
The biologically' important porphyrins are of type Ill.

I
I
I
I
I
I
I

They are associated with a small proportion of tY,Pe I porphy
rins.

Types II and IV are not known to occur 1n nature.
Type I porphyrins are found as uroporphyrin in congeni

tal porphyria.

It is considered to represent a fetal type

of pyrrole :metabolism vith the probable site of elaboration
being the mesalobl.Aete. Uroporphyrin I has also been ob
served in the peripher,- of the 11 ver lobules.
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In the meta-
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bolism of the porphJTins a certain proportion of tn,e I and
III cca;pounds are formed, the ratio being greatly in favor
of the tn,e I oompound.

The rate of excretion of copropor

phyrin I has been found to be directly proPortional to the
rate of for:ma.tion of protoporphyrin llI as nevhemoglob1n.
This bas been demonstrated in pernicious anemia and induced
hemo]-¥tio states.
Type III porphyrin as the uroporphyrin caapound is the
charaoterietic pigment excreted in acute idiopathic or acute
toxiQ porph)'ria.

I
I
I
I

It has been experimentally shown. that the

11ver can convert protoporphyrin to coproporplcyr1n. Except
for idiopathic porphyrin in which uroporphyr1n
coproporphyrin is usuaU,- formed.

1e excreted

Coproporpb.p-in porphyrin

ur1a occurs in two general situations :

(1) hepatic dysfune-

tion, as in cirlilosie, passive congestion, etc., and (2)
extra.hepatic, as in lead and sul:f'OnNllide etc. poisoning and
in rhe�tic feT.er.

The literature hae little to ofter of

a specific nature but does allow one to speculate.

In the

ca�� of hepatic d,y'stunction, it is not 1nconceivable that the
conversion of protoporphyrin to bile pig1118nt is interrupted,

I
I
I

in part at least, at a eoproporphyrin stage. In this �gard.,
the following diagram frca Everett ( 8) my be of interest:
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,saeme + H20
lfntogl.Obin-------...�l!bin

j,

Choleglobin +
Ji26 ----➔
(Peewlaheiqlobin)

➔ Protoporphyrin + FeO ·
l
iliverdin + 2H --} B111ru,in ♦ lOH
+
,J,
eO
Urobilin

-c

Gl!bin

-,.o

4211 l
Urobilinogen

j

·2:11

Su.lfanil.amide may produce what might quite properly' be

termed a secondary chronic porphyria or chronic porpbyria or

chronic porpbyrinuria. That ia photoaensitivity as in the con
genital type, aeute abdOJllinal a�tams as in the aeute type
and the characteristic copropo2"Ph,rin III excretion of the

chronic type.

It has been suggested that lead and the sulfonamide

drugs produce a porphyr1nuria b;y intorf'erring Vith the reac

tion;

protoporplcyrin +iron--·•·} heme.tin. What is this

mechanism! Recent work on rhell118.tio fever indicates that

there is a Widespread interference of the various constitu

ents involved in tissue oxidation. It does not then seem in

conceivabl.e that perpbJria in these conditions is due directly
or indireetly to the inhibition or destruction of an enzyme

� or enzymes having to

with "hematinogonesis•. And by a

similar mechanism an anemia might be possible through failure
do

of formation of protoporphyr1n or pyrrole. These last men
◄9--
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tioned are 1lllportant net only to the respiratory pigment hemo

globiJJ., bu.t to
Two

theories

beginning
with

With

cytochromes and cytochrome

the

of

porphyrinogenoaie

dipyrramethenes

and

the

oxidaee.

(l)

are presented;

beginning

oi.her (2}

s:1Jllple pyrrols and then involving a tripyrr�tha.ne atep.

'l'he J.Atter

is more

thec:>q

mental evidence that
and� vitro

from.

and ammonia have

appealing in the light of

porphyrins may

--

be synthesized in

gly�ine and acetate.

been

experi
Vivo

Acetoacetie ester

condensed to :form pyrroles, and por

phyrina ha.Ye been synthesized from. pyrrole and ald.ehydes •
. Assuming

that

the

principal

precursors of the

r1ns have been determined, there yet

remains

the

porphy

mechanism

and controlling factors { enzyme) involved in the synthesis
of

pyrrol precursor to pyrrol

When

this

is acccmpliahed a

and

pyrrol to porphyrin.

more ratiol¥Ll.

therapy

of

the

idiopathic porphyrias and probabl.J certain drug intoxica
tions as well as rheumatic fever JJJ13J be

developed.

.I

I
I
I
I
I
I

...
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ADDENDUM
In a recent article, Linas et al (82) gives a report of,
a case of chronic porphyria complicated by pregnancy. A pre ..
l1mjna:ry- report of this case was made b7 �lor et al (ll7).
The patient, a twenty year old primigra.nda, presented
herself 1n June, 1945, at which time she was tvo months preg•
na.nt.

She appeared normal at this t1me except for numerous

veeicul.ar lesions and slightly brown pigmented pockmarks of'
earlier cutaneous lesions scattered over the arms, legs, neck
and f'a.ee (expoeed areas). At this t:1:me she was on the
f'olloving treatment regimen, under which her uriDa.ry porphy
rin excretion dro� f'ram 1,200 to l,6oo micrograms to a.ppro.x1-tely 800 to 1,000 micrograms of porpbirin a clay;
oalciua lactate 2.6

gin.,

sodium bicarbonate 5.2 gm• ., and

ribof'laVin 40 DIS• by- mouth daily;

in addition, one am.pule

of Solu B ( th18Dl.ine hydrochloride 10 :mg. , riboflavin 10 :mg. ,
pyrid.oxine hydrochloride 5 :mg., calcium pantothenate 50 :mg.

I
I
I
I
I
I
]

and n1cotin.Nl1de 250 :mg.) intraauacularl;r three times a week
and 15 U.S.P. unite of' llver extract once a week. Because
of the apparent 1-l)rovemnt the administration of SoluB and
liver extract was discontinued for one month.
In Jul.f there was a deo1de.d exacerbation and extension
of the cutaneous lesions.

Itching was marked.
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There was

I
I
I

proa.ounced ec18:ma or the ankles and she e�l.aioed of fre
quent cramps throughout both legs.

By August, 1945, the

skin lesions were worse 1n spite of the prertowslJ' :mentioned
therapy and the addition of a ta.nnic acid containing skin
l.otion, the avoidance of exposure to sunlight and the con
stant wearing

ot

black clothes.

The porphyrin excretion in

creased to 1,200 micrograms per cJAy' in August,

1945.

In- _

wrru.pti011 ot the pregnancy was coneider-ed because of the
progr&asion of the disease and the possibility of tr8M
mies1on of the disease to the off-spring through heredity.
In Ausust, 1945, the f'olloviDg thera.l)eutic schedule was
established.:

calo:f.wa lactate 2.6 Gm., and sodium l)icat"bon

ate 5.2 Gm. by mouth daily.

I
I
I
I
I
I

In addition she rece1Ted ribo

flavin 20 mg. ever1 four hours, ascorbic acid l,000 mg. every
four hours and nicotinaaide 100 JDS• tVioe daily, orally.

She

was g1 ven one am,pule of Solu B intram.useularl,y tVice weekly'.
Li-nr extract was discontinued.

The patient felt subjectively

better on this regimen, Yith new lesion appearing and heal.iag
as before.
Tb.a patient �livered on January 30, 194E> without the · ..
developm9nt of further ceeplica.tions.

It is of interest to

note tlB t the amniotic flu.14 contained high conoentrations
of coproporpbJ:?'in I and the placenta contained many calcar
eous deposits which were btUliantl.3 red. fluorescent under

I
I
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near ul.traviol.et light.
The baby' e urine contained sufficient porphyr1n to·-be
eVident spectroscopically' bu.t this dieappeared by the third
day.
AU "ant1:porph;yric11 :medication was stopped. ju.st prior
to clellvery.

Within forty-eight hours after deliver,- the

cutaneous lesions showed much :l.JD.provem&nt.-

At seven months

post-partmn there had been no exacerbations, new lesions
appearing from time to time t'olloving exposure to bright sun
light, but were i'"ev in number a� cleared up rapidly.

The

urinary porphyr1n excretion has dropped to 400 micrograms

I

per dAy, approx:1Jll&tel,:' four times the normal amount.
'!'he auth:ors (82) believe that chronic porphyria is
made worse during pregnancy, but that the totai e.xper1encei

I
I
I
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I

has a beneficial effect on the patient.

The pregnancy was

Wl8.f'f'eeted by the disease and the �ft-spring was apparentl.J'
normal.

Chronic porphyria is not llll indication for the

interruption of pregnancy.
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